scPharmaceuticals (SCPH)
(Delayed Data from NSDQ)
$5.31 USD
+0.20 (3.91%)
Updated Sep 12, 2024 03:59 PM ET
After-Market: $5.30 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.44 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.34 |
Next Year | -0.80 |
EPS (TTM) | -1.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.90M | 14.86M | 39.70M | 102.27M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 12.10M | 16.40M | 42.70M | 126.90M |
Low Estimate | 10.20M | 13.49M | 37.40M | 82.50M |
Year ago Sales | 3.80M | 6.10M | 13.59M | 39.70M |
Year over Year Growth Est. | 186.74% | 143.66% | 192.06% | 157.60% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.30 | -0.28 | -1.34 | -0.80 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.28 | -0.25 | -1.33 | -0.66 |
High Estimate | -0.28 | -0.25 | -1.25 | -0.55 |
Low Estimate | -0.33 | -0.34 | -1.47 | -1.10 |
Year ago EPS | -0.41 | -0.35 | -1.42 | -1.34 |
Year over Year Growth Est. | 26.83% | 20.00% | 5.63% | 40.30% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 2 | 2 | 1 |
Up Last 60 Days | 3 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 2 |
Down Last 60 Days | 0 | 1 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.28 | -1.34 | -0.80 |
7 Days Ago | -0.30 | -0.28 | -1.34 | -0.80 |
30 Days Ago | -0.37 | -0.33 | -1.44 | -0.75 |
60 Days Ago | -0.40 | -0.34 | -1.46 | -0.80 |
90 Days Ago | -0.40 | -0.34 | -1.46 | -0.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.30 | -0.28 | -1.37 | -0.80 |
Zacks Consensus Estimate | -0.30 | -0.28 | -1.34 | -0.80 |
Earnings ESP | 0.00% | 0.00% | -2.29% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.44 | -0.36 | -0.35 | -0.41 | NA |
Estimate | -0.44 | -0.45 | -0.42 | -0.36 | NA |
Difference | 0.00 | 0.09 | 0.07 | -0.05 | 0.03 |
Surprise | 0.00% | 20.00% | 16.67% | -13.89% | 5.70% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more